logo
Share SHARE
FONT-SIZE Plus   Neg

CafePress Prices IPO At $19/Share, Above Estimated Range

CafePress Inc, e-commerce platform enabling customers worldwide to create, buy and sell personalized products, announced the pricing of its initial public offering of 4.5 million common at $19.00 per share, above its estimated offering price range.

In an amended regulatory filing with the U.S. Securities and Exchange Commission on March 27, the company had expected to price the initial public offering of 4.5 million common shares between $16 and $18 per share.

The San Mateo, California-based company shares are expected to begin trading on The Nasdaq Global Select Market on March 29, 2012 under the symbol "PRSS."

Of the shares of common stock in the offering, CafePress is offering 2.5 million shares and selling stockholders are offering 2 million shares.

In addition, certain selling stockholders have granted underwriters a 30-day option to buy 675 thousand additional shares to cover over-allotments, if any.

The company intends to use the net proceeds from this offering for general corporate purposes, including working capital and capital expenditures. In addition, the company may use a portion of the net proceeds to acquire or invest in complementary businesses, products or technologies.

Founded in 1999, the company allows people to create their own designs for t-shirts, stickers, coffee mugs and other products, which the company then helps sell to customers.

J.P. Morgan Securities LLC and Jefferies & Company, Inc. are acting as joint book-running managers for the offering. Cowen and Company, LLC, Janney Montgomery Scott LLC and Raymond James & Associates, Inc. are acting as co-managers.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
British lender Lloyds Banking Group Plc. Friday reported higher profit in its first half, benefited by increased net interest income and margin as well as lower impairment. Looking ahead, the company lifted its net interest margin forecast. Amgen reported an increase in second-quarter profit, driven by sales of arthritis drug Enbrel and osteoporosis treatments Xgeva and Prolia, and improved margins. Both earnings and sales topped Wall Street estimates. Electronic Arts Inc. (EA) on Thursday reported an increase in profit for the first quarter, reflecting continued strong digital revenues, with both earnings and revenues topping Wall Street estimates. However, shares of the company fell over 4 percent, after having detailed a weak outlook. Redwood...
comments powered by Disqus
Follow RTT